AI has long been a trusted companion in the discovery and development of new technologies. Its role as a research tool is well-established, with inventors continually finding new ways to utilise AI in assisting with the creation of innovative solutions. But can AI-assisted inventions secure patent protection?
Read more
The European Patent Office (EPO) approach to assessing AI inventions can provide strategic advantages in progressing corresponding Australian patent applications through examination, offering real value for those looking to enhance their global patent portfolio.
Read more
bioRxiv article that introduces Germinal, a broadly enabling generative framework that designs antibodies against specific epitopes with nanomolar binding affinities while requiring only low-n experimental testing.
Read more
xplore how advances in in silico protein modelling are opening new frontiers for both defensive and offensive IP strategies in the article featured in AusBiotech’s latest “Australasian Biotechnology” journal. From designing around existing antibody patents to expanding claim scope through predicted sequence variants, these approaches are transforming how patent portfolios are built and protected in the biotech space. See page 40-41.
Read more
Read more